Burden of liver diseases in the world.

Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis and 1million due to viral hepatitis and hepatocellular carcinoma. Cirrhosis is currently the 11th most common cause of death globally and liver cancer is the 16th leading cause of death; combined, they account for 3.5% of all deaths worldwide. Cirrhosis is within the top 20 causes of disability-adjusted life years and years of life lost, accounting for 1.6% and 2.1% of the worldwide burden. About 2 billion people consume alcohol worldwide and upwards of 75 million are diagnosed with alcohol-use disorders and are at risk of alcohol-associated liver disease. Approximately 2 billion adults are obese or overweight and over 400 million have diabetes; both of which are risk factors for non-alcoholic fatty liver disease and hepatocellular carcinoma. The global prevalence of viral hepatitis remains high, while drug-induced liver injury continues to increase as a major cause of acute hepatitis. Liver transplantation is the second most common solid organ transplantation, yet less than 10% of global transplantation needs are met at current rates. Though these numbers are sobering, they highlight an important opportunity to improve public health given that most causes of liver diseases are preventable.

[1]  M. Rela,et al.  Liver transplantation in India , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  J. Shao,et al.  Population-representative Incidence of Acute-On-Chronic Liver Failure , 2016, Journal of clinical gastroenterology.

[3]  W. Choe,et al.  Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition , 2016, PloS one.

[4]  G. Davey Smith,et al.  Supplementary Tables , 2009 .

[5]  Hao Li,et al.  Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies , 2015, World Journal of Surgical Oncology.

[6]  Aijaz Ahmed,et al.  Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. , 2014, Hepatology.

[7]  Chao-Long Chen,et al.  Why does living donor liver transplantation flourish in Asia? , 2013, Nature Reviews Gastroenterology &Hepatology.

[8]  Zhen Wang,et al.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  M. Miquel,et al.  Natural history of patients hospitalized for management of cirrhotic ascites. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  Yan Liu,et al.  Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment , 2010, Environmental health perspectives.

[11]  Min Zheng,et al.  Acute‐on‐chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults , 2015, Hepatology.

[12]  D. J. Kim,et al.  A Prospective Nationwide Study of Drug-Induced Liver Injury in Korea , 2012, The American Journal of Gastroenterology.

[13]  H. Bonkovsky,et al.  Herbal products and the liver: a review of adverse effects and mechanisms. , 2015, Gastroenterology.

[14]  M. Manns,et al.  Hepatitis D virus infection—Not a vanishing disease in Europe! , 2007, Hepatology.

[15]  H. Thomas,et al.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.

[16]  A. Burroughs,et al.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.

[17]  A. George Compassionate Cities: Public Health and End-of-Life Care , 2006 .

[18]  J. Lazarus,et al.  Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention , 2014, PloS one.

[19]  A. Israni,et al.  OPTN/SRTR 2015 Annual Data Report: Liver , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  Marc J Gunter,et al.  Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment , 2018, The lancet. Diabetes & endocrinology.

[21]  G. Hirschfield,et al.  EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. , 2017, Journal of hepatology.

[22]  G. Gores,et al.  Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  P. Bedossa,et al.  Risk factors of fibrosis in alcohol‐induced liver disease , 2002, Hepatology.

[24]  M. Manns,et al.  Autoimmune hepatitis , 2018, Nature Reviews Disease Primers.

[25]  S. Franceschi,et al.  Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[26]  K. McGlynn,et al.  Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. , 2015, Clinics in liver disease.

[27]  F. Capron,et al.  Excess weight risk factor for alcoholic liver disease , 1997, Hepatology.

[28]  Noele P. Nelson,et al.  Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. , 2016, Clinics in liver disease.

[29]  B. Ludviksson,et al.  The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study , 2012, European journal of gastroenterology & hepatology.

[30]  H. Devarbhavi Acute Liver Failure Induced by Anti-infectious Drugs: Causes and Management , 2017, Current Hepatology Reports.

[31]  J. Miller,et al.  Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. , 1972, Cancer research.

[32]  H. Dalton,et al.  Antibiotic therapy: a major cause of drug-induced jaundice in southwest England , 2007, European journal of gastroenterology & hepatology.

[33]  C. Ponsioen,et al.  Rising incidence and prevalence of primary biliary cirrhosis: a large population‐based study , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[34]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[35]  R. Matesanz,et al.  How Spain Reached 40 Deceased Organ Donors per Million Population , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  C. Mulder,et al.  Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands , 2014, Scandinavian journal of gastroenterology.

[37]  K. Lindor,et al.  Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis , 2004, American Journal of Gastroenterology.

[38]  Chien-Jen Chen,et al.  Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: A 20‐year cohort study of 3.8 million vaccinees , 2014, Hepatology.

[39]  M. Buti,et al.  Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population. , 2018, Journal of hepatology.

[40]  Y. Li,et al.  Comparison of Current Diagnostic Criteria for Acute-On-Chronic Liver Failure , 2015, PloS one.

[41]  H. Margolis,et al.  Population-Based Surveillance for Acute Liver Failure , 2007, The American Journal of Gastroenterology.

[42]  C. Ponsioen,et al.  Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. , 2012, Journal of hepatology.

[43]  Andrew X. Zhu,et al.  Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise , 2016, The oncologist.

[44]  D. Rockey,et al.  Development of a novel clinical staging model for cirrhosis using the Nationwide Inpatient Sample , 2018, Journal of Investigative Medicine.

[45]  M. Stepanova,et al.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[46]  Chien-Jen Chen,et al.  Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.

[47]  J. Talwalkar,et al.  Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study , 2019, The American Journal of Gastroenterology.

[48]  J. Neuberger,et al.  The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study. , 2013, Journal of hepatology.

[49]  Y. Chawla,et al.  Etiology and mode of presentation of chronic liver diseases in India: A multi centric study , 2017, PloS one.

[50]  J. Neyts,et al.  Update on hepatitis E virology: Implications for clinical practice. , 2016, Journal of hepatology.

[51]  Mohsen Naghavi,et al.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis , 2014, BMC Medicine.

[52]  Ramon Planas,et al.  Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. , 2005, The New England journal of medicine.

[53]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[54]  Jason A. Dominitz,et al.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. , 2015, Gastroenterology.

[55]  J. Wendon,et al.  Acute liver failure. , 2013, The New England journal of medicine.

[56]  A. Urueña,et al.  Impact of the Single-dose Immunization Strategy Against Hepatitis A in Argentina , 2014, The Pediatric infectious disease journal.

[57]  F. Negro,et al.  EASL Clinical Practice Guidelines on hepatitis E virus infection. , 2018, Journal of hepatology.

[58]  D. Couper,et al.  Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide. , 2016, Journal of hepatology.

[59]  P. Loehrer,et al.  Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level , 2007 .

[60]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.

[61]  E. Björnsson,et al.  Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic , 2006, Alimentary pharmacology & therapeutics.

[62]  M. Merli,et al.  Incidence and natural history of small esophageal varices in cirrhotic patients. , 2003, Journal of hepatology.

[63]  G. D’Amico,et al.  Clinical states of cirrhosis and competing risks. , 2017, Journal of hepatology.

[64]  E. Kalaitzakis,et al.  Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure , 2015, Scandinavian journal of gastroenterology.

[65]  H. El‐Serag,et al.  The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.

[66]  J. West,et al.  The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study , 2010, Alimentary pharmacology & therapeutics.

[67]  William M. Lee,et al.  Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[68]  D. J. Kim,et al.  Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis , 2016, World journal of gastroenterology.

[69]  Li Yang,et al.  Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21 789 patients , 2013, European journal of gastroenterology & hepatology.

[70]  G. Lee,et al.  Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk. , 2016, Gastroenterology.

[71]  L. Henry,et al.  Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. , 2016, Clinics in liver disease.

[72]  F. Negro,et al.  Hepatitis D virus: an update , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[73]  L. Y. Wang,et al.  Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study , 2001, British Journal of Cancer.

[74]  H. Wedemeyer,et al.  Hepatitis delta virus , 2011, The Lancet.

[75]  Angelique Zeringue,et al.  Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. , 2011, Gastroenterology.

[76]  K. Jacobsen,et al.  Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. , 2010, Vaccine.

[77]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[78]  M. Stepanova,et al.  Direct and Indirect Economic Burden of Chronic Liver Disease in the United States , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[79]  Timothy D Phillips,et al.  Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. , 2004, The American journal of clinical nutrition.

[80]  G. Song,et al.  Liver transplantation in Korea: past, present, and future. , 2015, Transplantation proceedings.

[81]  G. Folkers,et al.  Incidence of drug-induced liver injury in medical inpatients , 2005, European Journal of Clinical Pharmacology.

[82]  J. Izopet,et al.  Hepatitis E , 2012, The Lancet.

[83]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[84]  B. Henderson,et al.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[85]  John R Lake,et al.  The Survival Impact of Liver Transplantation in the MELD Era, and the Future for Organ Allocation and Distribution , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[86]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[87]  M. Elazar,et al.  A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus–infected mongolians , 2016, Hepatology.

[88]  G. McCaughan,et al.  Liver transplantation in Australia and New Zealand , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[89]  W. Cooksley What did we learn from the Shanghai hepatitis A epidemic? , 2000, Journal of viral hepatitis.

[90]  R. Andrade,et al.  Drug-Induced Liver Injury Due to Antimicrobials, Central Nervous System Agents, and Nonsteroidal Anti-Inflammatory Drugs , 2014, Seminars in Liver Disease.

[91]  C. Wild,et al.  Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. , 2008, Annual Review of Public Health.

[92]  F. Tacke,et al.  Liver transplantation in Germany , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[93]  C. Ф. Галимова Хронический гепатит D , 2015 .

[94]  M. Plummer,et al.  World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma , 2015, Hepatology.

[95]  K. Reddy,et al.  Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures , 2014, Hepatology.

[96]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[97]  J. Samet,et al.  Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. , 2004, Journal of the National Cancer Institute.

[98]  D. Ribero,et al.  Current Status on Cholangiocarcinoma and Gallbladder Cancer , 2016, Liver Cancer.

[99]  J. Lazarus,et al.  Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. , 2018, Journal of hepatology.

[100]  T. Morgan,et al.  Alcohol and hepatocellular carcinoma. , 2004, Gastroenterology.

[101]  M. M. Rahman,et al.  Worldwide trends in diabetes since 1980 : pooled analysis of 751 population-based measurement studies with over 4 . 4 million participants , 2016 .

[102]  M. Buti,et al.  The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B , 2017, Hepatology.

[103]  J. Fonseca,et al.  Comment to: "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease". , 2017, Journal of hepatology.

[104]  M. Mcphail,et al.  Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. , 2013, Journal of hepatology.

[105]  A. Walker,et al.  Causes of Death in People with Liver Cirrhosis in England Compared with the General Population: A Population-Based Cohort Study , 2015, The American Journal of Gastroenterology.

[106]  P. Hillon,et al.  Incidence of drug‐induced hepatic injuries: A French population‐based study , 2002, Hepatology.

[107]  Robert Blissett,et al.  The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe , 2016, Hepatology.

[108]  W. Kim,et al.  Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure , 2016, Seminars in Liver Disease.

[109]  Eliseo Guallar,et al.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. , 2013, American journal of epidemiology.

[110]  S. Bird,et al.  Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[111]  V. Wong,et al.  Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis , 2013, Hepatology.

[112]  M. Rizzetto Chronic Hepatitis D; at a Standstill? , 2016, Digestive Diseases.

[113]  D. Preen,et al.  The evolving epidemiology of hepatocellular carcinoma: a global perspective , 2015, Expert review of gastroenterology & hepatology.

[114]  H. Barnhart,et al.  Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network , 2014, Hepatology.

[115]  M. Manns,et al.  Cutting edge issues in autoimmune hepatitis. , 2016, Journal of autoimmunity.

[116]  H. Grønbæk,et al.  Cirrhosis and mortality risks of biopsy‐verified alcoholic pure steatosis and steatohepatitis: a nationwide registry‐based study , 2012, Alimentary pharmacology & therapeutics.

[117]  Jürgen Rehm,et al.  Global burden of alcoholic liver diseases. , 2013, Journal of hepatology.

[118]  William M. Lee,et al.  Outcomes in Adults With Acute Liver Failure Between 1998 and 2013 , 2016, Annals of Internal Medicine.

[119]  H. Jick,et al.  A Review of Epidemiologic Research on Drug‐Induced Acute Liver Injury Using the General Practice Research Data Base in the United Kingdom , 1997, Pharmacotherapy.

[120]  G. Gores,et al.  Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States , 2017, Cancer.

[121]  A. Burroughs,et al.  Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. , 2014, Gastroenterology.

[122]  L. Tavoschi,et al.  Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups , 2018, BMC Infectious Diseases.

[123]  P. Haberman,et al.  Liver cirrhosis with and without mention of alcohol as cause of death. , 1990, British journal of addiction.

[124]  Ahmedin Jemal,et al.  Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer , 2016, Cancer.

[125]  Magnus Rattray,et al.  A genetic study of Wilson's disease in the United Kingdom. , 2013, Brain : a journal of neurology.

[126]  A. Bergquist,et al.  Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis , 2017, Scandinavian journal of gastroenterology.

[127]  Giacomo Germani,et al.  Renal failure and cirrhosis: a systematic review of mortality and prognosis. , 2012, Journal of hepatology.

[128]  M. Yamada,et al.  Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery , 2016, Journal of Gastroenterology.

[129]  Gretchen A. Stevens,et al.  The global burden of hepatitis E virus genotypes 1 and 2 in 2005 , 2012, Hepatology.

[130]  P. van Damme,et al.  Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. , 2017, Journal of hepatology.

[131]  M. Charlton,et al.  The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health , 2016, Hepatology.

[132]  M. Mondelli,et al.  Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. , 2009, Journal of hepatology.

[133]  A. Nicolucci,et al.  The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes , 2016, Journal of diabetes research.

[134]  F. Gottrand,et al.  The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration , 2017, Hepatology.

[135]  Terry M. Therneau,et al.  Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.

[136]  J. Jónasson,et al.  Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease , 2014, BMC Gastroenterology.

[137]  K. Lindor,et al.  Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[138]  Å. Danielsson,et al.  Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. , 1996, Gut.

[139]  A. Urueña,et al.  Single-dose Universal Hepatitis A Immunization in One-year-old Children in Argentina: High Prevalence of Protective Antibodies up to 9 Years After Vaccination , 2016, The Pediatric infectious disease journal.

[140]  H. El‐Serag,et al.  Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? , 2014, Hepatology.

[141]  Hai-rim Shin,et al.  Epidemiology of cholangiocarcinoma: An update focusing on risk factors , 2010, Cancer science.

[142]  T. Gruenberger,et al.  Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[143]  J. Rehm,et al.  Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010. , 2013, Alcohol research : current reviews.

[144]  V. Bhatia,et al.  A 20‐year single‐center experience with acute liver failure during pregnancy: Is the prognosis really worse? , 2008, Hepatology.

[145]  A. Chetwynd,et al.  Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. , 2002, Gastroenterology.

[146]  F. D. de Abajo,et al.  Acute and clinically relevant drug-induced liver injury: a population based case-control study. , 2004, British journal of clinical pharmacology.

[147]  A. Bergquist,et al.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. , 2002, Journal of hepatology.

[148]  U. Nöthlings,et al.  Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. , 2011, Journal of the National Cancer Institute.

[149]  Katherine M Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[150]  A. Zhernakova,et al.  Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. , 2014, Gastroenterology.

[151]  M. Manns,et al.  The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[152]  Vikram Patel,et al.  Global burden of diseases, injuries, and risk factors for young people's health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2016, The Lancet.

[153]  J. Aronson,et al.  Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature , 2016, BMC Medicine.

[154]  P. Rosenthal,et al.  Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. , 2006, The Journal of pediatrics.

[155]  O. Traynor,et al.  Liver transplantation in Ireland , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[156]  T. Karlsen,et al.  Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease. , 2016, Gastroenterology.

[157]  J. Trotter,et al.  Liver transplantation around the world , 2016, Liver transplantation.

[158]  Jürgen Rehm,et al.  Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders , 2009, The Lancet.

[159]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[160]  S. Eguchi,et al.  Liver transplantation in Japan , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[161]  Jennifer L. Lund,et al.  Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. , 2015, Gastroenterology.

[162]  Y. Ko,et al.  Habitual Betel Quid Chewing and Risk for Hepatocellular Carcinoma Complicating Cirrhosis , 2004, Medicine.

[163]  T. Vos,et al.  Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.

[164]  T. Todorov,et al.  Wilson Disease Mutation Pattern with Genotype‐Phenotype Correlations from Western India: Confirmation of p.C271* as a Common Indian Mutation and Identification of 14 Novel Mutations , 2013, Annals of human genetics.

[165]  M. Cole,et al.  Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. , 2014, Journal of hepatology.

[166]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[167]  G. D’Amico,et al.  Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients , 2014, Alimentary pharmacology & therapeutics.

[168]  Youming Li,et al.  Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study , 2013, The American Journal of Gastroenterology.

[169]  W. Stremmel,et al.  EASL Clinical Practice Guidelines: Wilson's disease. , 2012, Journal of hepatology.

[170]  M. L. de la Mata,et al.  Acute liver failure in Spain: Analysis of 267 cases , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[171]  Mathieu Laversanne,et al.  International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007 , 2016, International journal of cancer.

[172]  C. Couto,et al.  Liver Transplantation in Brazil , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[173]  Gérard Krause,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[174]  M. Yuen,et al.  Nonalcoholic fatty liver disease in Asia: emerging perspectives , 2017, Journal of Gastroenterology.

[175]  G. Esmat,et al.  The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm , 2014, Journal of viral hepatitis.

[176]  C. Pairojkul,et al.  Cholangiocarcinoma: lessons from Thailand , 2008, Current opinion in gastroenterology.

[177]  T. Therneau,et al.  Epidemiology and natural history of primary biliary cirrhosis in a US community. , 2000, Gastroenterology.

[178]  William M. Lee,et al.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. , 2015, Gastroenterology.

[179]  P. Kamath,et al.  Time trends in the health care burden and mortality of acute on chronic liver failure in the United States , 2016, Hepatology.

[180]  Gretchen A. Stevens,et al.  Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults , 2017, Lancet.

[181]  B. Li,et al.  Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis , 2012, BMC Cancer.

[182]  A. Diehl,et al.  Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis , 2017, The New England journal of medicine.

[183]  E. Björnsson,et al.  Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports , 2016, Hepatology.

[184]  Detlef Schuppan,et al.  Liver cirrhosis , 2008, The Lancet.

[185]  E. Rigopoulou,et al.  Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study , 2018 .

[186]  S. Kedia,et al.  Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients , 2017, Digestive Diseases and Sciences.

[187]  A. Moorman,et al.  Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[188]  Baolin Wang,et al.  Causes and Outcomes of Acute Liver Failure in China , 2013, PloS one.

[189]  R. Moreau,et al.  Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. , 2016, Scientific Reports.

[190]  F. Vleggaar,et al.  Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis , 2013, Hepatology.

[191]  D. Corley,et al.  Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. , 2008, The American journal of medicine.

[192]  W. Kremers,et al.  Single-Center Experience With Drug-Induced Liver Injury From India: Causes, Outcome, Prognosis, and Predictors of Mortality , 2010, The American Journal of Gastroenterology.

[193]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[194]  Ding‐Shinn Chen,et al.  Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. , 2003, Gastroenterology.

[195]  M. Salminen,et al.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening , 2013, BMC Infectious Diseases.

[196]  H. Tilg,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[197]  Z. Abbas,et al.  Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016 , 2016, Hepatology International.

[198]  C. Fondevila,et al.  Liver transplantation in Spain , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[199]  Rohit Loomba,et al.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease , 2017, Hepatology.

[200]  T. Therneau,et al.  Biliary Tract Cancers in Olmsted County, Minnesota, 1976–2008 , 2012, The American Journal of Gastroenterology.

[201]  W. Palmer,et al.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. , 2012, Journal of hepatology.

[202]  Yan-Qing Li,et al.  Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis , 2011, Cancer Causes & Control.

[203]  J. West,et al.  All‐cause mortality in people with cirrhosis compared with the general population: a population‐based cohort study , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[204]  H. Thomas,et al.  Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? , 2012, Journal of hepatology.

[205]  H. El‐Serag,et al.  Risk factors for cholangiocarcinoma , 2011, Hepatology.

[206]  H. Kim,et al.  Epidemiology, predictors and outcomes of multi drug resistant bacterial infections in patients with cirrhosis across the world. Final results of the “Global study” , 2018 .

[207]  P. A. Futreal,et al.  Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool , 2013, Science Translational Medicine.

[208]  H. Vilstrup,et al.  Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. , 2014, Journal of hepatology.

[209]  S. Olafsson,et al.  Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. , 2013, Gastroenterology.

[210]  T. Karlsen,et al.  Primary sclerosing cholangitis - a comprehensive review. , 2017, Journal of hepatology.

[211]  T. O'Brien,et al.  Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. , 2006, Journal of the National Cancer Institute.

[212]  Alan D. Lopez,et al.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.

[213]  G. Gores,et al.  Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. , 2013, Gastroenterology.

[214]  A. Burroughs,et al.  Impact of primary biliary cirrhosis on perceived quality of life: The UK‐PBC national study , 2013, Hepatology.

[215]  Reza Assadi,et al.  The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 , 2016, The Lancet.

[216]  Rajvir Singh,et al.  Drug‐induced acute liver failure in children and adults: Results of a single‐centre study of 128 patients , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[217]  Y. Ni,et al.  Hepatitis B vaccination in children: the Taiwan experience. , 2010, Pathologie-biologie.

[218]  H. El‐Serag,et al.  Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[219]  F. Carrat,et al.  Large‐scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis , 2017, Hepatology.

[220]  J. Neuberger Liver transplantation in the United Kingdom , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[221]  P. Woo,et al.  New Hepatitis E Virus Genotype in Bactrian Camels, Xinjiang, China, 2013 , 2016, Emerging infectious diseases.

[222]  H. Sørensen,et al.  Clinical course of alcoholic liver cirrhosis: A Danish population‐based cohort study , 2010, Hepatology.

[223]  A. Bergquist,et al.  Epidemiology of cholangiocarcinoma. , 2015, Best practice & research. Clinical gastroenterology.

[224]  Jaw-Town Lin,et al.  Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. , 2013, Journal of hepatology.

[225]  T. Patel Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[226]  E. Ferguson,et al.  An international comparison of deceased and living organ donation/transplant rates in opt-in and opt-out systems: a panel study , 2014, BMC Medicine.

[227]  L. Serino,et al.  Hepatitis A: Epidemiology and prevention in developing countries. , 2012, World journal of hepatology.

[228]  J. Trinchet,et al.  Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features , 2007, Alimentary pharmacology & therapeutics.

[229]  B. Graubard,et al.  Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States , 2013, The American Journal of Gastroenterology.

[230]  L. Scobie,et al.  Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study , 2015, Alimentary pharmacology & therapeutics.